Table 4.
Demographic summary of subjects used in the in vitro eosinophil function study.
| Healthy controls | Mild AR | Moderate-severe AR | P value | |
|---|---|---|---|---|
| Total subjects, n | 4 | 4 | 4 | — |
| Gender, male/female | 2/2 | 2/2 | 2/2 | — |
| Age (years) | 22.5 (22, 25.25) | 25.5 (22.75, 26.75) | 25.5 (22, 30.5) | 0.665 |
| History of smoking (%) | 0 | 0 | 0 | — |
| SPT to Der p | Negative | Positive | Positive | — |
| Total IgE (KU/l) | 29.3 (12.1, 46.5) | 95.2 (87.5, 102.9) | 180.1 (113.8, 246.4) | 0.001 |
| Specific IgE to Der p (KU/l) | 0.05 (0.04, 0.06) | 27.8 (10.95, 43.98) | 76.35 (32.68, 94.3) | 0.001 |
For continuous variables, data are expressed by medians and interquartile ranges. AR: allergic rhinitis; SPT: skin prick test; Der p: Dermatophagoides pteronyssinus; Ig: immunoglobulin.